Abstract
AbstractBackgroundThe ongoing coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has changed cancer treatment. However, specific guidelines for patients with oral cancer and SARS‐CoV‐2 infection, especially for chemoradiation therapy (CRT), are lacking.Case PresentationWe report a case of a woman with oral squamous cell carcinoma diagnosed with SARS‐CoV‐2 nosocomial infection, although she had no COVID‐19 symptoms, while undergoing superselective intra‐arterial CRT. She received sotrovimab while continuing CRT and achieved a complete response.ConclusionThe general condition of the patient and the CRT regimen characteristics should be considered in the treatment of patients with COVID‐19 and cancer.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
